Showing 4,281 - 4,300 results of 5,177 for search 'National Key Universities', query time: 0.10s Refine Results
  1. 4281
  2. 4282
  3. 4283

    Effects of Baicalin on Gout Based on Network Pharmacology, Molecular Docking, and in vitro Experiments by Liu C, Liu W, Lu H, Fan Y, Wang A

    Published 2025-02-01
    “…Chunliu Liu,1– 3,* Wei Liu,1,2,* Hang Lu,1,2 Yihua Fan,4 Aihua Wang1,2 1Department of Rheumatism and Immunity, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China; 2National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, People’s Republic of China; 3Department of Respiratory Medicine, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, People’s Republic of China; 4Department of Rheumatism and Immunity, Hospital of Chengdu University of Traditional Chinese Medicine, Sichuan Chengdu, People’s Republic of China*These authors contributed equally to this workCorrespondence: Wei Liu, Email fengshiliuwei@163.comPurpose: Baicalin is a flavonoid of Scutellaria baicalensis Georgi. …”
    Get full text
    Article
  4. 4284

    A New Risk Score Based on Lipid Indicators for Patients with Advanced Hepatocellular Carcinoma by Wei X, Guo Z, Zhang T, Liang J

    Published 2025-01-01
    “…Xing Wei,1 Ziwei Guo,2 Tingting Zhang,3 Jun Liang1 1Department of Medical Oncology, Peking University International Hospital, Beijing, People’s Republic of China; 2Department of Medicine, Double Crane Runchuang Technology (Beijing) Co., Ltd, Beijing, People’s Republic of China; 3Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Diseases, Beijing, People’s Republic of ChinaCorrespondence: Jun Liang, Email Junl1959@163.comBackground: The prognosis is extremely troubling in advanced hepatocellular carcinoma (HCC). …”
    Get full text
    Article
  5. 4285
  6. 4286

    GPX3 as a Novel and Potential Therapeutic Target in the Shared Molecular Mechanisms of Traumatic Brain Injury and Parkinson’s Disease by Wang Y, Fang J, Yuan Q, Yu J, Hu J

    Published 2025-02-01
    “…Yue Wang,1– 5 Jiang Fang,1– 5 Qiang Yuan,1– 5 Jian Yu,1– 5 Jin Hu1– 5 1Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, 200040, People’s Republic of China; 2National Center for Neurological Disorders, Huashan Hospital, Fudan University, Shanghai, 200040, People’s Republic of China; 3Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Huashan Hospital, Fudan University, Shanghai, 200040, People’s Republic of China; 4Neurosurgical Institute of Fudan University, Huashan Hospital, Fudan University, Shanghai, 200040, People’s Republic of China; 5Shanghai Clinical Medical Center of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, 200040, People’s Republic of ChinaCorrespondence: Jian Yu; Jin Hu, Department of Neurosurgery, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, People’s Republic of China, Tel +86 21 52889999, Email hujin@fudan.edu.cn; lance2000@hotmail.comBackground: Traumatic brain injury (TBI) is a prevalent neurological disorder associated with significant public health burdens and long-term risks, including neurodegenerative diseases such as Parkinson’s disease (PD). …”
    Get full text
    Article
  7. 4287
  8. 4288
  9. 4289
  10. 4290
  11. 4291
  12. 4292
  13. 4293
  14. 4294
  15. 4295
  16. 4296
  17. 4297
  18. 4298
  19. 4299
  20. 4300